Posts Tagged ‘veterinary use’

FDA and Responsible Opioid Prescribing for Pain Management in Animals

The Food and Drug Administration (FDA) continues to address the opioid epidemic on all fronts with regards to prescribing opioids in humans. But, last month, the FDA introduced a new resource containing information and recommendations specifically for veterinarians who stock and administer opioids. The FDA recommends veterinarians take the following steps if they stock and…

Read More

FDA’s Efforts to Advance Antimicrobial Stewardship in Veterinary Settings

Antimicrobial drugs, when used correctly, fight infections, but when antimicrobials are overused or misused, they promote antimicrobial resistant bacteria. Efforts at implementing good antimicrobial stewardship practices have been a mainstay in human healthcare for years and remains a top priority of the Food and Drug Administration (FDA). However, over the passed few years the FDA…

Read More

Veterinary Compounding: Recent State Legislation Updates

State boards of pharmacy continue to have primary responsibility of the day-to-day oversight of state-licensed pharmacies that compound drugs in accordance with Section 503A of the Food and Drug Cosmetic Act (FDCA) while the FDA regulates and inspects registered outsourcing facilities licensed under Section 503B of the FDCA. While the exact definition of compounding may vary…

Read More

Louisiana Board of Pharmacy Addresses the Compounding of Veterinarian Only Drugs for Office Use

Earlier this year, the Louisiana Board of Pharmacy (Louisiana Board) exercised the emergency provision of the Louisiana Administrative Procedure Act (R.S. 49:9.53.B), to amend its rules governing the compounding of drugs by pharmacies and restored the capability for pharmacies to compound drugs intended for the administration by veterinarians without the necessity of a patient-specific prescription.…

Read More